Effects of Bifidobacterium-based interventions on patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized clinical trials
Digestive Diseases · 05.11.2026
DOI: 10.1159/ddi/acnag015 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Digestive Diseases, online erschienen am 05.11.2026. Verfasst von Hongkai Chang und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Bifidobacterium has showcased potential benefits in managing irritable bowel syndrome (IBS) symptoms.
Methods
We systematically searched online databases up until 1 December 2025, to identify randomized, double-blind, placebo-controlled trials investigating the efficacy of Bifidobacterium-based or Bifidobacterium-containing preparations in IBS patients. Pooled analyses of the effects of these interventions on IBS symptom relief were calculated using a random-effects model. Subgroup analyses were conducted based on different regions, doses, and treatment durations.
Results
Eight RCTs encompassing 1,304 patients were identified. Bifidobacterium-based interventions demonstrated significant improvements in overall response rate (RR: 1.99; 95% CI: 1.63–2.43; P < 0.00001), abdominal pain relief (RR: 2.09; 95% CI: 1.36–3.24; P = 0.0009), and subjective relief (RR: 1.62; 95% CI: 1.28–2.05; P < 0.0001). Significant benefits were observed in both adult (RR: 1.94; 95% CI: 1.58–2.40; P < 0.00001) and pediatric cohorts (RR: 2.86; 95% CI: 1.33–6.15; P = 0.007). However, subgroup comparisons showed comparable efficacy between daily dosages of < 10¹⁰ and ≥ 10¹⁰ CFU (P = 0.65) and between treatment durations of < 8 and ≥ 8 weeks (P = 0.33).
Conclusions
Bifidobacterium-based interventions effectively alleviate IBS symptoms, particularly abdominal pain and subjective discomfort, in both adults and children. However, current evidence does not demonstrate superiority for specific doses or extended durations, precluding definitive conclusions regarding optimal posology.
Systematic review registration
PROSPERO registration no. CRD420251252390.
Zitieren
APA
Chang, H., Song, H., Shi, L., & Li, P. (2026). Effects of Bifidobacterium-based interventions on patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized clinical trials. Digestive Diseases. https://doi.org/10.1159/ddi/acnag015
Vancouver
Chang H, Song H, Shi L, Li P. Effects of Bifidobacterium-based interventions on patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized clinical trials. Digestive Diseases. 2026. doi:10.1159/ddi/acnag015
BibTeX
@article{Chang2026,
author = {Chang, Hongkai and Song, Huixin and Shi, Lubo and Li, Peng},
title = {Effects of Bifidobacterium-based interventions on patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized clinical trials},
journal = {Digestive Diseases},
year = {2026},
doi = {10.1159/ddi/acnag015}
}
EUVIMED